Accessibility Statement

Evaric Pharmaceuticals is committed to ensuring digital accessibility for all visitors, including those with disabilities. We are actively working to improve the accessibility of our website in line with WCAG 2.1 AA standards.

Measures taken include: semantic HTML structure with proper heading hierarchy and landmarks, keyboard-accessible navigation with visible focus indicators, skip-to-content link for screen reader and keyboard users, support for reduced-motion preferences to disable non-essential animations, sufficient color contrast throughout the design, and descriptive text for meaningful images with null alt attributes for decorative content.

If you experience any accessibility barrier while using this website, please contact us through the contact page and include the specific page URL, the assistive technology you are using (if relevant), and a detailed description of the issue so we can address it.

This statement will be updated as accessibility improvements are made and as WCAG or regulatory requirements evolve. Final accessibility language, including compliance timelines and conformance claims, should be reviewed and approved by qualified counsel before public launch.

PLACEHOLDER - This accessibility statement is review-ready content. Replace with counsel-approved language, including specific conformance level (A/AA/AAA), evaluation date, and any known limitations, before public launch.